Overview

The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients

Status:
Unknown status

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

Hypothesis: Peripheral blood Very Small Embryonic-like Stem Cells (VSELs) are different in coronary artery disease (CAD) patients from those without CAD, which might account for the benefits of Atorvastatin in CAD patients.

Phase:

Phase 4

Details

Lead Sponsor:

Ji Huang

Collaborator:

National Natural Science Foundation of China

Treatments:

Atorvastatin
Atorvastatin Calcium
Hydroxymethylglutaryl-CoA Reductase Inhibitors